Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology

DNA and Cell Biology

Volumn 23, Issue 6, 2004, Pages 341-350

  Bot, Adrian ^a,c   Smith, Kent A ^a   Von Herrath, Matthias ^b  

^a MannKind Corporation   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; STAT4 PROTEIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CELL DIFFERENTIATION; CELL POPULATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DEFENSE MECHANISM; HOMEOSTASIS; HUMAN; HYPOTHESIS; IMMUNE SYSTEM; INFLUENZA VIRUS; LUNG; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TRANSCRIPTION REGULATION; VIRUS; VIRUS INFECTION;

CELL DIFFERENTIATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-4; MODELS, IMMUNOLOGICAL; ORTHOMYXOVIRIDAE; STAT4 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS;

BACTERIA (MICROORGANISMS); INFLUENZA VIRUS;

EID: 3042823637     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904323145227     Document Type: Review

References (71)

1. ABBAS, A.K., MURPHY, K.M., and SHER, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
2. AVNI, O., LEE, D., MACIAN, F., SZABO, S.J., GLIMCHER, L.H., and RAO, A. (2002). T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat. Immunol. 3, 643-651.
3. BENTON, K.A., MISPLON, J.A., LO, C.Y., BRUTKIEWICZ, R.R., PRASAD, S.A., and EPSTEIN, S.L. (2001). Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta cells. J. Immunol. 166, 7437-7445.
4. BERTOLINO, P., TRESCOL-BIEMONT, M.C., THOMAS, J., FAZEKAS DE ST GROTH, B., PIHLGREN, M., MARVEL, J., and RABOURDIN-COMBE, C. (1996). Death by neglect as a deletional mechanism of peripheral tolerance. Int. Immunol. 11, 1225-1238.
5. BOGOMOL'TSEV, B.P., and DEVIATKIN, A.V. (2003). Clinical implications of impaired microcirculation and hemodynamics in acute respiratory viral infections and their pharmacological correction. Klin. Med. (Mosk.) 81, 9-15.
6. BOT, A., HOLZ, A., CHRISTEN, U., WOLFE, T., TEMANN, A., FLAVELL, R., and VON HERRATH, M. (2000). Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses. Virology 269, 66-77.
7. BOT, A., RODRIGO, E., WOLFE, T., BOT, S., and VON HERRATH, M.G. (2003). Infection-triggered regulatory mechanisms override the role of STAT 4 in control of the immune response to influenza virus antigens. J. Virol. 77, 5794-5800.
8. BROMLEY, S.K., BURACK, W.R., JOHNSON, K.G., SOMERSALO, K., SIMS, T.N., SUMEN, C., DAVIS, M.M., SHAW, A.S., ALLEN, P.M., and DUSTIN, M.L. (2001). The immunological synapse. Annu. Rev. Immunol. 19, 375-396.
9. CALLARD, R.E., STARK, J., and YATES, A.J. (2003). Fratricide: A mechanism for T memory-cell homeostasis. Trends Immunol. 24, 370-375.
10. CARDING, S.R., ALLAN, W., MCMICKLE, A., and DOHERTY, P.C. (1993). Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia. J. Exp. Med. 177, 475-482.
11. CARTER, L.L., and MURPHY, K.M. (1999). Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J. Exp. Med. 189, 1355-1360.
12. CHAKIR, H., WANG, H., LEFEBVRE, D.E., WEBB, J., and SCOTT, F.W. (2003). T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: Predominant role of GATA-3. J. Immunol. Methods 278, 157-169.
13. DALTON, D.K., PITTS-MEEK, S., KESHAV, S., FIGARI, I.S., BRADLEY, A., and STEWART, T.A. (1993). Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742.
14. DE JONG, E.C., VIEIRA, P.L., KALINSKI, P., SCHUITEMAKER, J.H., TANAKA, Y., WIERENGA, E.A., YAZDANBAKHSH, M., and KAPSENBERG, M.L. (2002). Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J. Immunol. 168, 1704-1709.
15. DEL PRETE, G., and ROMAGNANI, S. (1994). The role of TH1 and TH2 subsets in human infectious diseases. Trends Microbiol. 2, 4-6.
16. FINKELMAN, F.D., and URBAN, J.F., JR. (2001). The other side of the coin: the protective role of the TH2 cytokines. J. Allergy Clin. Immunol. 107, 772-780.
17. HANLON, A.M., JANG, S., and SALGAME, P. (2002). Signaling from cytokine receptors that affect Th1 responses. Front. Biosci. 7, d1247-1254.
18. HO, I.C., HODGE, M.R., ROONEY, J.W., and GLIMCHER, L.H. (1996). The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
19. HO, I.C., LO, D., and GLIMCHER, L.H. (1998). c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188, 1859-1866.
20. HODGE, M.R., CHUN, H.J., RENGARAJAN, J., ALT, A., LIEBERSON, R., and GLIMCHER, L.H. (1996). NF-AT-driven interleukin-4 transcription potentiated by NIP45. Science 274, 1903-1905.
21. HOLZ, A., BOT, A., COON, B., WOLFE, T., GRUSBY, M.J., and VON HERRATH, M.G. (1999). Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J. Immunol. 163, 5374-5382.
22. HUANG, H., and PAUL, W.E. (1998). Impaired interleukin 4 signaling in T helper type 1 cells. J. Exp. Med. 187, 1305-1313.
23. KADOWAKI, N., ANTONENKO, S., HO, S., RISSOAN, M.C., SOUMELIS, V., PORCELLI, S.A., LANIER, L.L., and LIU, Y.J. (2001). Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193, 1221-1226.
24. KAMBAYASHI, T., ASSARSSON, E., CHAMBERS, B.J., and LJUNGGREN, H.G. (2001). Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Eur. J. Immunol. 31, 1523-1530.
25. KAPLAN, M.H., SCHINDLER, U., SMILEY, S.T., and GRUSBY, M.J. (1996a). Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
26. KAPLAN, M.H., SUN, Y.L., HOEY, T., and GRUSBY, M.J. (1996b). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
27. KAPLAN, M.H., WURSTER, A.L., and GRUSBY, M.J. (1998). A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188, 1191-1196.
28. KATAMURA, K., SHINTAKU, N., YAMAUCHI, Y., FUKUI, T., OHSHIMA, Y., MAYUMI, M., and FURUSHO, K. (1995). Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J. Immunol. 155, 4604-4612.
29. KIANI, A., VIOLA, J.P., LICHTMAN, A.H., and RAO, A. (1997). Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity 7, 849-860.
30. LALVANI, A., BROOKES, R., HAMBLETON, S., BRITTON, W.J., HILL, A.V., McMICHEAL, A.J. (1997). Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186, 859-865.
31. LEFRAK, E.A., STEVENS, P.M., PITHA, J., BALSINGER, E., NOON, G.P., and MAYOR, H.D. (1974). Extracorporeal membrane oxygenation for fulminant influenza pneumonia. Chest 66, 385-388.
32. LI-WEBER, M., and KRAMMER, P.H. (2003). Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol. 3, 534-543.
33. LIGHVANI, A.A., FRUCHT, D.M., JANKOVIC, D., YAMANE, H., ALIBERTI, J., HISSONG, B.D., NGUYEN, B.V., GADINA, M., SHER, A., PAUL, W.E., et al. (2001). T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98, 15137-15142.
34. MBAWUIKE, I.N., ACUNA, C.L., WALZ, K.C., ATMAR, R.L., GREENBERG, S.B., and COUCH, R.B. (1997). Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech. Ageing Dev. 94, 25-39.
35. MORAN, T.M., ISOBE, H., FERNANDEZ-SESMA, A., and SCHULMAN, J.L. (1996). Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J. Virol. 70, 5230-5235.
36. MOSMANN, T.R., and SAD, S. (1996). The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
37. MOSMANN, T.R., CHERWINSKI, H., BOND, M.W., GIEDLIN, M.A., and COFFMAN, R.L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
38. MURPHY, K.M., OUYANG, W., SZABO, S.J., JACOBSON, N.G., GULER, M.L., GORHAM, J.D., GUBLER, U., and MURPHY, T.L. (1999). T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. Curr. Top. Microbiol. Immunol. 238, 13-26.
39. NOBEN-TRAUTH, N., PAUL, W.E., and SACKS, D.L. (1999). IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162, 6132-6140.
40. O'GARRA, A., and ARAI, N. (2000). The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10, 542-550.
41. OUYANG, W., RANGANATH, S.H., WEINDEL, K., BHATTACHARYA, D., MURPHY, T.L., and SHA, W.C. (1998). Murphy KM inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9, 745-755.
42. PEARCE, E.L., MULLEN, A.C., MARTINS, G.A., KRAWCZYK, C.M., HUTCHINS, A.S., ZEDIAK, V.P., BANICA, M., DICIOCCIO, C.B., GROSS, D.A., MAO, C.A., et al. (2003). Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043.
43. PITCHER, L.A., and VAN OERS, N.S. (2003). T-cell receptor signal transmission: Who gives an ITAM? Trends Immunol. 24, 554-560.
44. RANGANATH, S., OUYANG, W., BHATTARCHARYA, D., SHA, W.C., GRUPE, A., PELTZ, G., and MURPHY, K.M. (1998). GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826.
45. RANGER, A.M., HODGE, M.R., GRAVALLESE, E.M., OUKKA, M., DAVIDSON, L., ALT, F.W., DE LA BROUSSE, F.C., HOEY, T., GRUSBY, M., and GLIMCHER, L.H. (1998a). Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8, 125-134.
46. RANGER, A.M., OUKKA, M., RENGARAJAN, J., and GLIMCHER, L.H. (1998b). Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9, 627-635.
47. READ, S., and POWRIE, F. (2001). CD4(+) regulatory T cells. Curr. Opin. Immunol. 13, 644-649.
48. ROBINSON, D.S., and O'GARRA, A. (2002). Further checkpoints in Th1 development. Immunity 16, 755-758.
49. ROONEY, J.W., HODGE, M.R., MCCAFFREY, P.G., Rao, A., and GLIMCHER, L.H. (1994). A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J. 13, 625-633.
50. SAD, S., MARCOTTE, R., and MOSMANN, T.R. (1995). Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2, 271-279.
51. SHIMODA, K., VAN DEURSEN, J., SANGSTER, M.Y., SARAWAR, S.R., CARSON, R.T., TRIPP, R.A., CHU, C., QUELLE, F.W., NOSAKA, T., VIGNALI, D.A., et al. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
52. SHIMOMURA, E., SUZUKI, F., and ISHIDA, N. (1982). Characterization of cells infiltrating the lungs of x-irradiated and nude mice after influenza virus infection. Microbiol. Immunol. 26, 129-138.
53. STAMM, L.M., RAISANEN-SOKOLOWSKI, A., OKANO, M., RUSSELL, M.E., DAVID, J.R., and SATOSKAR, A.R. (1998). Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol. 161, 6180-6188.
54. SUGAWARA, I., YAMADA, H., MIZUNO, S., and IWAKURA, Y. (2000). IL-4 is required for defense against mycobacterial infection. Microbiol. Immunol. 44, 971-979.
55. SUNDRUD, M.S., GRILL, S.M., NI, D., NAGATA, K., ALKAN, S.S., SUBRAMANIAM, A., and UNUTMAZ, D. 2003. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J. Immunol. 171, 3542-3549.
56. SZABO, S.J., JACOBSON, N.G., DIGHE, A.S., GUBLER, U., and MURPHY, K.M. (1995). Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2, 665-675.
57. SZABO, S.J., KIM, S.T., COSTA, G.L., ZHANG, X., FATHMAN, C.G., and GLIMCHER, L.H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669.
58. SZALAY, G., LADEL, C.H., BLUM, C., and KAUFMANN, S.H. (1996). IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. J. Immunol. 157, 4746-4750.
59. TAKEDA, K., KISHIMOTO, T., and AKIRA, S. (1997). STAT6: Its role in interleukin 4-mediated biological functions. J. Mol. Med. 75, 317-326.
60. TAKEDA, K., TANAKA, T., SHI, W., MATSUMOTO, M., MINAMI, M., KASHIWAMURA, S., NAKANISHI, K., YOSHIDA, N., KISHIMOTO, T., and AKIRA, S. (1996). Essential role of Stat6 in IL-4 signalling. Nature 380, 627-630.
61. TANIGUCHI, M., HARADA, M., KOJO, S., NAKAYAMA, T., and WAKAO, H. (2003). The regulatory role of Valpha14 NKT cells in innate and aquired immune responses. Annu. Rev. Immunol. 21, 483-513.
62. TARLETON, R.L., GRUSBY, M.J., and ZHANG, L. (2000). Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J. Immunol. 165, 1520-1525.
63. TRINCHIERI, G. (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146.
64. URBAN, J.F. JR., KATONA, I.M., PAUL, W.E., and FINKELMAN, F.D. (1991). Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc. Natl. Acad. Sci. USA 88, 5513-5517.
65. VAN PARIJS, L., PEREZ, V.L., and ABBAS, A.K. (1998). Mechanisms of peripheral T cell tolerance. Novartis Found. Symp. 215, 5-14.
66. VENKATARAMAN, C., LEUNG, S., SALVEKAR, A., MANO, H., and SCHINDLER, U. (1999). Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation. J. Immunol. 162, 4053-4061.
67. VON HERRATH, M.G., and HARRISON, L.C. (2003). Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3, 223-232.
68. WANG, L., SMITH, D., BOT, S., DELLAMARY, L., BLOOM, A., and BOT, A. (2002). Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J. Clin. Invest. 110, 1175-1184.
69. WELLS, M.A., ALBRECHT, P., and ENNIS, F.A. (1981). Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J. Immunol. 126, 1036-1041.
70. YAMAMOTO, K., QUELLE, F.W., THIERFELDER, W.E., KREIDER, B.L., GILBERT, D.J., JENKINS, N.A., COPELAND, N.G., SILVENNOINEN, O., and IHLE, J.N. (1994). Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol. Cell Biol. 14, 4342-4349.
71. ZHENG, W., and FLAVELL, R.A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596.